Sean Lee

Stock Analyst at HC Wainwright & Co.

(3.98)
# 576
Out of 5,182 analysts
97
Total ratings
33.68%
Success rate
19.75%
Average return
Main Sectors:

Stocks Rated by Sean Lee

Dogwood Therapeutics
Apr 27, 2026
Reiterates: Buy
Price Target: $12
Current: $1.44
Upside: +733.33%
Akari Therapeutics,
Apr 1, 2026
Maintains: Buy
Price Target: $1.6$27
Current: $5.62
Upside: +380.43%
Novavax
Feb 27, 2026
Maintains: Buy
Price Target: $11$16
Current: $8.10
Upside: +97.53%
Kazia Therapeutics
Jan 28, 2026
Reiterates: Buy
Price Target: $18
Current: $13.45
Upside: +33.83%
Plus Therapeutics
Jan 23, 2026
Maintains: Buy
Price Target: $50$25
Current: $6.22
Upside: +301.93%
Corvus Pharmaceuticals
Jan 20, 2026
Maintains: Buy
Price Target: $11$27
Current: $15.70
Upside: +71.97%
Alphatec Holdings
Jan 12, 2026
Reiterates: Buy
Price Target: $24
Current: $10.23
Upside: +134.60%
Cytosorbents
Nov 14, 2025
Maintains: Neutral
Price Target: $1$0.75
Current: $0.61
Upside: +23.95%
Senseonics Holdings
Nov 6, 2025
Maintains: Buy
Price Target: $1.4$19
Current: $5.00
Upside: +270.00%
Myomo
Aug 12, 2025
Maintains: Buy
Price Target: $9.5$5
Current: $0.88
Upside: +469.87%
Maintains: Buy
Price Target: $10$14
Current: $5.96
Upside: +134.90%
Reiterates: Buy
Price Target: $40
Current: $56.88
Upside: -29.68%